A.P. Møller - Mærsk A/S
13.4.2026 11:03:01 CEST | Globenewswire | Press release
Transactions in connection with share buy-back program
Transactions in connection with share buy-back program
ANNOUNCEMENT
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
On 5 February 2026, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 6.3bn (around USD 1bn) to be executed over a period of 12 months. The first phase of the share buy-back program will run from 9 February 2026 up to 5 August 2026. The shares to be acquired will be limited to a total market value of DKK 3.15 billion (around USD 500m).
The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).
The following transactions have been made under the program in the period 06 April to 10 April 2026:
| Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
| Accumulated, last announcement | 11,914 | 190,419,060 | |
| 6 April 2026 | - | - | - |
| 7 April 2026 | 300 | 15,667.5667 | 4,700,270 |
| 8 April 2026 | 300 | 15,451.9000 | 4,635,570 |
| 9 April 2026 | 300 | 15,770.3667 | 4,731,110 |
| 10 April 2026 | 300 | 15,685.6667 | 4,705,700 |
| Total 6-10 April 2026 | 1,200 | 18,772,650 | |
| Accumulated in the second phase of the program | 13,114 | 209,191,710 | |
| Accumulated under the program | 13,114 | 209,191,710 | |
| Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
| Accumulated, last announcement (market and the Foundation) | 47,656 | 772,818,333 | |
| 6 April 2026 | - | - | - |
| 7 April 2026 | 1,052 | 15,966.6778 | 16,796,945 |
| 8 April 2026 | 1,052 | 15,715.5228 | 16,532,730 |
| 9 April 2026 | 1,052 | 16,039.1540 | 16,873,190 |
| 10 April 2026 | 1,052 | 15,930.8555 | 16,759,260 |
| Total 6-10 April 2026 | 4,208 | 66,962,125 | |
| Bought from the Foundation* | 592 | 15,913.0525 | 9,420,527 |
| Accumulated in the second phase of the program (market and the Foundation) | 52,456 | 849,200,985 | |
| Accumulated under the program (market and the Foundation) | 52,456 | 849,200,985 |
*) According to a separate agreement, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (the Foundation) participates on a pro rata basis to the shares purchased in the share buy-back program.
With the transactions stated above, the Company owns a total of 193,908 A shares and 1,147,385 B shares as treasury shares, corresponding to 8.47% of the share capital.
Details of each transaction are included as appendix.
Copenhagen, 13 April 2026
Contact persons:
Head of Investor Relations, Martin Dunwoodie, tel. +45 3363 3484
Head of Media Relations, Jesper Lov, tel. +45 6114 1521
Page 1 of 1
Attachments
- Announcement - Transactions in connection with share buy-back program - week 15 2026
- Daily transactions in connection with share buy-back program - week 15 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Schneider Electric19.4.2026 09:00:00 CEST | Press release
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage
Chery Group18.4.2026 15:54:00 CEST | Press release
iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology
Sanofi Winthrop Industrie18.4.2026 12:00:00 CEST | Press release
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Organizing Committee of the 2026 Fujian Provincial Conference on the Development of Cultural and Tourism Economy18.4.2026 06:50:27 CEST | Press release
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's Fujian
Evaxion17.4.2026 21:10:00 CEST | Press release
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom